A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/56 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2562356
The present invention provides a method of treatment of an individual with an ophthalmic condition comprising the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound is an anti-oedematous steroid, more preferably a mineralocorticoid.
Une méthode de traitement d'un individu souffrant d'une pathologie ophtalmique consistant à: administrer à l'individu une quantité thérapeutiquement efficace d'un composé apte à moduler l'activité des récepteurs de minéralocorticoïdes au sein des cellules ou d'un tissu se trouvant dans l'oeil ou adjacent à l'oeil de l'individu soumis au traitement. Le composé est de préférence, un stéroïde anti-oedémateux, de préférence un minéralocorticoïde.
Penfold Philip Leslie
Peyman Gholam Ali
Sanders Donald Robert
Advanced Ocular Systems Limited
Peyman Gholam Ali
Retmed Pty Ltd
Sanders Donald Robert
Sim & Mcburney
LandOfFree
Treatment of ophthalmic conditions with mineralcorticoids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of ophthalmic conditions with mineralcorticoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ophthalmic conditions with mineralcorticoids will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1773267